Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal osteodystrophy.

J T McCarthy1, R Kumar

  • 1Division of Nephrology and Internal Medicine, Mayo Clinic, Rochester, Minnesota.

Endocrinology and Metabolism Clinics of North America
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A suitable current stabilizer for the Tiselius apparatus.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010
Same author

Preliminary experience with a cuffed ePTFE graft for hemodialysis vascular access.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2001
Same author

Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure.

The American journal of cardiology·2001
Same author

Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.

American journal of nephrology·2001
Same author

Is calciphylaxis best treated surgically or medically?

Surgery·2000
Same author

Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers.

Mayo Clinic proceedings·2000
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Renal osteodystrophy, a bone disorder in kidney failure, has five subtypes. Understanding its causes, like vitamin D deficiency and high phosphate, is key to preventing hyperparathyroidism and guiding treatment.

Area of Science:

  • Nephrology
  • Endocrinology
  • Histopathology

Background:

  • Renal osteodystrophy is a complex bone disorder in patients with chronic kidney disease.
  • It manifests in five distinct histologic subtypes: mild bone disease, hyperparathyroid bone disease, mixed bone disease, osteomalacia, and low-turnover bone disease.

Purpose of the Study:

  • To outline the subtypes of renal osteodystrophy.
  • To discuss the etiologies of hyperparathyroidism in renal failure.
  • To highlight the role of aluminum and parathyroid hormone in specific bone disease subtypes.

Main Methods:

  • Review of the histologic classification of renal osteodystrophy.
  • Discussion of the pathophysiology of hyperparathyroidism in renal failure.
  • Analysis of factors influencing osteomalacia, mixed, and low-turnover bone disease.

Related Experiment Videos

Main Results:

  • Hyperparathyroidism in renal failure stems from 1,25(OH)2D3 deficiency and hyperphosphatemia.
  • Aluminum status and parathyroid hormone levels significantly impact osteomalacia, mixed, and low-turnover bone disease.
  • Aluminum-associated bone disease can be managed by discontinuing aluminum exposure or using deferoxamine.

Conclusions:

  • Accurate diagnosis of renal osteodystrophy subtypes is crucial for effective management.
  • Bone biopsy is essential for avoiding diagnostic pitfalls and tailoring therapeutic strategies.
  • Addressing vitamin D deficiency, hyperphosphatemia, and aluminum toxicity is vital in managing renal osteodystrophy.